Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...
EDOF technology, previously used in intraocular lenses, is now available in contact lenses, offering significant improvements ...
Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...
Hemodialysis significantly alters anterior and posterior eye segments, affecting parameters like anterior chamber depth, lens ...
The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
The world’s first dedicated hypotony clinic, funded by Moorfields Eye Charity, has been established at the Moorfields Eye ...
SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...
Nanoscope has received a new patent ( US Patent No. 12459977) from the US Patent and Trademark Office (USPTO) for the company ...
“The non-invasive in vivo optical imaging of rhodopsin activation extends the diagnostic capability of ORG and may facilitate ...
Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...
Greenland sharks possess a DNA repair mechanism that maintains vision over centuries, preventing retinal degeneration despite ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback